Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease
Keith A. Betts, PhD,
Sasikiran Nunna, PhD,
Retesh Kumar, MD,
Xiaoyu Nie, PhD,
Ancilla W. Fernandes, PhD
Affiliations
Keith A. Betts, PhD
Analysis Group, Inc, Los Angeles, CA
Sasikiran Nunna, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ; Address for Correspondence: Sasikiran Nunna, PhD, Otsuka Pharmaceutical Development & Commercialization, Inc, 508 Carnegie Center Dr, Princeton, NJ 08540.
Retesh Kumar, MD
Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ
Xiaoyu Nie, PhD
Analysis Group, Inc, Los Angeles, CA
Ancilla W. Fernandes, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ